Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

16
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

214
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Hazard Ratio01:12

Hazard Ratio

186
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
186

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Fibrosis-4 Index, Hepatic Biomarkers, and Plasma Acute-Phase Reactants in Critical Patients Undergoing Percutaneous Endoscopic Gastrostomy: A Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Associations Between Major Depressive Disorder, Multimorbidity Burden, and Inflammatory Biomarkers (NLR, PLR, MLR, SII, and MHR) in a Primary Care Population.

Journal of clinical medicine·2026
Same author

Treatment Outcomes of Presacral Pilonidal Sinus Disease Using Crystallised Phenol: A Single-Centre Clinical Series.

International wound journal·2026
Same author

Peripheral Blood IL-6 and STAT3 Gene Expression as Biomarkers Associated with Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer: A Prospective Cross-Sectional Study.

Breast cancer (Dove Medical Press)·2026
Same author

A comprehensive endoscopic and clinical evaluation of Cameron ulcers: Insights from a single-center cross-sectional experience.

Medicine·2026
Same author

Toward risk-informed prophylaxis after bariatric surgery: a measured reading of registry data.

Updates in surgery·2026

Related Experiment Video

Updated: Aug 5, 2025

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

14.7K

FAR Ratio as Prognostic Biomarker in AMI.

Ali Muhtaroğlu1, Recayi Çapoğlu2, Furkan Ali Uygur1

  • 1Department of General Surgery, Giresun University Faculty of Medicine, Giresun University Training and Research Hospital, Aksu District, Mehmet İzmen Street, Number: 145, 28100 Giresun, PC Turkey.

SN Comprehensive Clinical Medicine
|March 27, 2023
PubMed
Summary

The fibrinogen-to-albumin (FAR) ratio may predict outcomes in acute mesenteric ischemia (AMI) patients. Higher FAR ratios were linked to increased mortality in AMI, suggesting its prognostic value.

Keywords:
Acute mesenteric ischemiaAlbuminFibrinogenFibrinogen-to-albumin ratioPrognosis

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

156
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.6K

Related Experiment Videos

Last Updated: Aug 5, 2025

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

14.7K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

156
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.6K

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Critical Care Medicine

Background:

  • Acute mesenteric ischemia (AMI) is a critical vascular condition with high mortality.
  • Early identification of prognostic markers is crucial for managing AMI patients.

Purpose of the Study:

  • To evaluate the prognostic significance of the fibrinogen-to-albumin (FAR) ratio in patients diagnosed with AMI.

Main Methods:

  • A retrospective study involving 91 AMI patients.
  • Collected demographic and laboratory data, including pre- and postoperative fibrinogen and albumin levels.
  • Calculated the FAR ratio and compared values between survivor and non-survivor groups.

Main Results:

  • Non-survivors exhibited significantly higher pre- and postoperative fibrinogen levels and FAR ratios compared to survivors.
  • Non-survivors showed significantly lower pre- and postoperative albumin levels than survivors.
  • Significant differences in fibrinogen, albumin, and FAR ratio changes were observed between groups.

Conclusions:

  • The fibrinogen-to-albumin (FAR) ratio is a potential prognostic biomarker for acute mesenteric ischemia.
  • Elevated FAR ratios are associated with increased mortality in AMI patients.
  • FAR ratio can aid in risk stratification and management of AMI.